3,5-Dioxa-8-aza-4-phosphaoctacos-19-en-1-aminium, 4-hydroxy-7-[(1R,2E)-1-hydroxy-2-hexadecen-1-yl]-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (7S,19Z)-

Request For Quotation
3,5-Dioxa-8-aza-4-phosphaoctacos-19-en-1-aminium, 4-hydroxy-7-[(1R,2E)-1-hydroxy-2-hexadecen-1-yl]-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (7S,19Z)- Suppliers list
Company Name: Xingji Pharmaceutical (Shanghai) Co., Ltd  
Tel: 15705593425
Email: support@utgene.com
Company Name: Taizhou Chuanxu Pharmaceutical Technology Co., Ltd.  
Tel: chuanxupharma@126.co
Email: chuanxupharma@126.com
Company Name: TargetMol  
Tel: 400-821-0310 15002144251
Email: xuexiang.shao@tsbiochem.com
3,5-Dioxa-8-aza-4-phosphaoctacos-19-en-1-aminium, 4-hydroxy-7-[(1R,2E)-1-hydroxy-2-hexadecen-1-yl]-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (7S,19Z)- Basic information
Product Name:3,5-Dioxa-8-aza-4-phosphaoctacos-19-en-1-aminium, 4-hydroxy-7-[(1R,2E)-1-hydroxy-2-hexadecen-1-yl]-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (7S,19Z)-
Synonyms:3,5-Dioxa-8-aza-4-phosphaoctacos-19-en-1-aminium, 4-hydroxy-7-[(1R,2E)-1-hydroxy-2-hexadecen-1-yl]-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (7S,19Z)-;C20 Sphingomyelin (d18:1/20:1)
CAS:222403-67-0
MF:C43H85N2O6P
MW:757.13
EINECS:
Product Categories:
Mol File:222403-67-0.mol
3,5-Dioxa-8-aza-4-phosphaoctacos-19-en-1-aminium, 4-hydroxy-7-[(1R,2E)-1-hydroxy-2-hexadecen-1-yl]-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (7S,19Z)- Structure
3,5-Dioxa-8-aza-4-phosphaoctacos-19-en-1-aminium, 4-hydroxy-7-[(1R,2E)-1-hydroxy-2-hexadecen-1-yl]-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (7S,19Z)- Chemical Properties
Safety Information
MSDS Information
3,5-Dioxa-8-aza-4-phosphaoctacos-19-en-1-aminium, 4-hydroxy-7-[(1R,2E)-1-hydroxy-2-hexadecen-1-yl]-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (7S,19Z)- Usage And Synthesis
UsesC20 Sphingomyelin (d18:1/20:1) (SM:20:1) is a sphingomyelin. C20 Sphingomyelin (d18:1/20:1) is promising for research of motor neuron diseases such as amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS)[1].
References[1] Area-Gomez E, et al. Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders. Sci Rep. 2021 Jun 30;11(1):13562. DOI:10.1038/s41598-021-92112-3
3,5-Dioxa-8-aza-4-phosphaoctacos-19-en-1-aminium, 4-hydroxy-7-[(1R,2E)-1-hydroxy-2-hexadecen-1-yl]-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (7S,19Z)- Preparation Products And Raw materials
Tag:3,5-Dioxa-8-aza-4-phosphaoctacos-19-en-1-aminium, 4-hydroxy-7-[(1R,2E)-1-hydroxy-2-hexadecen-1-yl]-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (7S,19Z)-(222403-67-0) Related Product Information
2-Tetradecanol, 1,1′-[[2-[2-[4-[2-[[2-[2-[bis(2-hydroxytetradecyl)amino]ethoxy]ethyl](2-hydroxytetradecyl)amino]ethyl]-1-piperazinyl]ethoxy]ethyl]imino]bis- 4A3-SC8 DSG-PEG 2000 DODAP 1,2-Distearoyl-sn-glycero-3-phosphocholine DSPE-PEG-Mal